First Time Loading...

Nuvo Pharmaceuticals Inc
TSX:MRV

Watchlist Manager
Nuvo Pharmaceuticals Inc Logo
Nuvo Pharmaceuticals Inc
TSX:MRV
Watchlist
Price: 1.35 CAD Market Closed
Updated: May 4, 2024

Nuvo Pharmaceuticals Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Nuvo Pharmaceuticals Inc
Revenue Peer Comparison

Comparables:
BHC
WEED
CRON
C
CURA
T
TER

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Nuvo Pharmaceuticals Inc
TSX:MRV
Revenue
CA$72.4m
CAGR 3-Years
10%
CAGR 5-Years
31%
CAGR 10-Years
11%
Bausch Health Companies Inc
TSX:BHC
Revenue
$8.8B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
4%
Canopy Growth Corp
TSX:WEED
Revenue
CA$298.1m
CAGR 3-Years
-16%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Revenue
$87.2m
CAGR 3-Years
23%
CAGR 5-Years
48%
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Revenue
$2.3B
CAGR 3-Years
71%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Terrascend Corp
CNSX:TER
Revenue
$247.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Nuvo Pharmaceuticals Inc's Revenue?
Revenue
72.4m CAD

Based on the financial report for Sep 30, 2022, Nuvo Pharmaceuticals Inc's Revenue amounts to 72.4m CAD.

What is Nuvo Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
11%

Over the last year, the Revenue growth was 6%. The average annual Revenue growth rates for Nuvo Pharmaceuticals Inc have been 10% over the past three years , 31% over the past five years , and 11% over the past ten years .